Click a link below to view the mailing archive as if it had been sent to you.
| 2024-10-31 12:15 | | Amgen reaps Horizon buyout rewards in Q3 as it gears up for key biosim launches and more... |
| 2024-10-31 00:15 | | Exactech Files for Bankruptcy in Response to 2,600 Lawsuits Over Recalled Implants and more... |
| 2024-10-30 12:15 | | Lilly shares fall as obesity drug sales miss forecasts and more... |
| 2024-10-30 00:15 | | Lexicon's revised Zynquista bid in type 1 diabetes faces lingering safety questions and more... |
| 2024-10-29 12:15 | | Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales and more... |
| 2024-10-29 00:15 | | Revolution Medicines Targets Hard-to-Treat Pancreatic Cancer With Two Early-Phase Readouts and more... |
| 2024-10-28 12:15 | | Where Big Pharma’s campaign cash is flowing in this election and more... |
| 2024-10-28 00:15 | | After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah and more... |
| 2024-10-25 12:15 | | J&J, Eli Lilly pad immunology profiles with trial readouts in new patient groups and more... |
| 2024-10-25 00:15 | | Arcus' new HIF-2a data in kidney cancer hint at potential edge over Merck's Welireg, analysts say and more... |
| 2024-10-24 12:30 | | Weight-loss drugs didn't curb health costs within two years and more... |
| 2024-10-24 12:15 | | Weight-loss drugs didn't curb health costs within two years and more... |
| 2024-10-24 00:15 | | In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines and more... |
| 2024-10-23 12:15 | | Merck sets sights on brain cancer with $30M Modifi acquisition and more... |
| 2024-10-23 00:15 | | Senators probe whether Pfizer, Lilly DTC platforms create 'potential for inappropriate prescribing' and more... |
| 2024-10-22 12:15 | | Starboard wants to hold Pfizer leadership 'accountable' for overpaid M&A deals, poor return on R&D investment and more... |
| 2024-10-22 00:15 | | Radiopharma CDMO Nucleus lays out plan to triple manufacturing capacity, add 100 jobs and more... |
| 2024-10-21 12:15 | | Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on and more... |
| 2024-10-21 00:15 | | Supernus’ depression drug improved symptoms in two hours in Phase IIa study and more... |
| 2024-10-18 12:15 | | Gilead withdraws bladder cancer drug in US after failed trial and more... |
| 2024-10-18 00:15 | | After rejections, AbbVie secures approval for Parkinson’s drug and more... |
| 2024-10-17 12:15 | | Sage lays off half of R&D team, shakes up C-suite again and more... |
| 2024-10-17 00:15 | | Why hundreds of US pharmacies are closing and more... |
| 2024-10-16 12:15 | | GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV and more... |
| 2024-10-15 12:15 | | J&J reports Q3 sales surge of 5.2% despite EPS decline due to M&A activity and more... |
| 2024-10-15 00:15 | | TPG, Blackstone bid for Bausch + Lomb in potential $14 billion deal and more... |
| 2024-10-14 12:15 | | Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals and more... |
| 2024-10-13 12:15 | | FDA to reconsider decision barring compounded versions of Lilly weight loss drug and more... |
| 2024-10-11 12:15 | | Gilead gives up on $15M MASH bet with Yuhan after mulling preclinical data and more... |
| 2024-10-11 00:15 | | Denali-Sanofi scraps mid-stage study for multiple sclerosis drug and more... |
| 2024-10-10 12:15 | | Novo Holdings-backed Booster takes off with protein degraders aimed at neurodegeneration and more... |
| 2024-10-10 00:15 | | FDA black box warning for antidepressants may have unintended consequences and more... |
| 2024-10-09 12:15 | | US releases preliminary list of $2 generic drugs for Medicare recipients and more... |
| 2024-10-09 00:15 | | Sage continues downslide as Alzheimer’s study fails and more... |
| 2024-10-08 12:15 | | Merck's Keytruda stages comeback in head and neck cancer with trial win in earlier-stage disease and more... |
| 2024-10-08 00:15 | | J&J discontinues late-stage study for bladder cancer drug and more... |
| 2024-10-07 12:15 | | Pfizer wins bid to invalidate GSK's patents over RSV vaccine and more... |
| 2024-10-07 00:15 | | Alnylam agrees to drop patent lawsuit against Moderna over Covid-19 vaccine and more... |
| 2024-10-04 12:15 | | [podcast]Breaking down BIOSECURE—Industry implications and what comes next and more... |
| 2024-10-04 00:15 | | BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval and more... |
| 2024-10-03 12:15 | | Novo Nordisk has mitigation plans to minimize disruption from port strikes and more... |
| 2024-10-03 00:15 | | Louisiana district court upholds state 340B contract pharmacy law and more... |
| 2024-10-02 12:15 | | High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project and more... |
| 2024-10-02 00:15 | | Why Tandem Diabetes Care Stock Took It on the Chin Tuesday and more... |
| 2024-10-01 12:15 | | 23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows and more... |
| 2024-10-01 00:15 | | As urged by the AHA and others, J&J tells HRSA it is abandoning proposed 340B rebate plan and more... |
